Literature DB >> 3611788

Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies.

F Perosa, S Ferrone.   

Abstract

BALB/c mice have been immunized with six anti-HLA Class II monoclonal antibodies (MoAb); the latter included MoAb CR11-462, Q5/6, and Q5/13 to monomorphic determinants, the anti-HLA-DR1,4,w6,w8,w9 MoAb AC1.59, the anti-HLA-DRw9 MoAb AB7ae9, and the anti-HLA-DQw3 MoAb AC6G. The six monoclonal antibodies markedly differ in their ability to induce anti-idiotypic antibodies, because the latter were not detected in the sera from the mice immunized with the MoAb AB7ae9 and with the MoAb AC6G. The MoAb AC1.59 and CR11-462 elicited antibodies to private idiotypes, and the MoAb Q5/6 and Q5/13 elicited antibodies to private and public idiotypes. The titer of the latter in the anti-MoAb Q5/6 antiserum appears to be markedly lower than that of the former ones; no marked difference was detected in the titer of the two types of antibodies in the anti-MoAb Q5/13 antiserum. Blocking experiments with a panel of monoclonal antibodies showed that the MoAb Q5/13 shares idiotypes with the anti-HLA Class I MoAb Q5/6, 127, and 441 and with the anti-HLA Class I MoAb CR11-351, Q1/28, Q6/64, and 6/31, but does not share idiotypes with any of the nine anti-human melanoma-associated antigen MoAb tested. The spectrotypes of the anti-MoAb CR11-462 and anti-MoAb Q5/13 antisera comprise two major components in the pH 6.2 to 6.7 range, that of the anti-MoAb Q5/6 antiserum comprises two major components in the pH 6.5 to 6.8 range, and that of the anti-MoAb AC1.59 antiserum comprises a number of components in the pH 5.6 to 7.2 range.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611788

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities.

Authors:  F Perosa; S Ferrone
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

2.  B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models.

Authors:  Benjamin B Kasten; Rebecca C Arend; Ashwini A Katre; Harrison Kim; Jinda Fan; Soldano Ferrone; Kurt R Zinn; Donald J Buchsbaum
Journal:  Nucl Med Biol       Date:  2017-01-10       Impact factor: 2.408

3.  212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models.

Authors:  Benjamin B Kasten; Abhishek Gangrade; Harrison Kim; Jinda Fan; Soldano Ferrone; Cristina R Ferrone; Kurt R Zinn; Donald J Buchsbaum
Journal:  Nucl Med Biol       Date:  2017-12-24       Impact factor: 2.408

4.  212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.

Authors:  Benjamin B Kasten; Patsy G Oliver; Harrison Kim; Jinda Fan; Soldano Ferrone; Kurt R Zinn; Donald J Buchsbaum
Journal:  Int J Mol Sci       Date:  2018-03-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.